My drive is to understand autoimmunity at a fundamental level: what causes it, what maintains the process long-term, and what fuels the flares… As a rheumatologist, I see new patients every week that struggle with devastating autoimmune complications. Their stories are the basis of our research in the lab.

I obtained my MD from Athens School of Medicine (Greece) in 2024. I joined the Apostolidis Lab to study the pathogenesis of SLE and other autoimmune conditions. Currently, my main objectives include investigating the loss of self-tolerance to endogenous nucleic acids as a disease mechanism in SLE and researching the role of extracellular vesicles in disease diagnosis, stratification and prognostication

IrAEs are autoimmune complications occurring in cancer patients receiving immune checkpoint inhibitors. I am studying the pathogenesis and development of such syndromes to improve the patient experience and elucidate the proximal events of autoimmunity development. I am using genomic, transcriptomic, and cytometric approaches to investigate the role of memory CD4+ and CD8+ T cells in the development of irAEs.

I am responsible for the recruitment of research subjects, data management, and collection of biospecimens for our immune-related adverse events cohort study. I hope that this work helps improve the management of autoimmune complications and patient outcomes.